microRNA information: hsa-miR-3065-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-3065-5p | miRbase |
Accession: | MIMAT0015066 | miRbase |
Precursor name: | hsa-mir-3065 | miRbase |
Precursor accession: | MI0014228 | miRbase |
Symbol: | MIR3065 | HGNC |
RefSeq ID: | NR_036151 | GenBank |
Sequence: | UCAACAAAAUCACUGAUGCUGGA |
Reported expression in cancers: hsa-miR-3065-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-3065-5p | NA | NA | "NA ......" | NA | NA |
hsa-miR-3065-5p | " ......" |
Reported cancer pathway affected by hsa-miR-3065-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|
Reported cancer prognosis affected by hsa-miR-3065-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|
Reported gene related to hsa-miR-3065-5p
miRNA | cancer | gene | reporting | PUBMED |
---|
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-3065-5p | BNC2 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.244; TCGA CESC -0.158; TCGA ESCA -0.211; TCGA LUAD -0.131; TCGA LUSC -0.274; TCGA PAAD -0.334; TCGA PRAD -0.214; TCGA THCA -0.182; TCGA UCEC -0.276 |
hsa-miR-3065-5p | ETS1 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.194; TCGA CESC -0.148; TCGA ESCA -0.19; TCGA LGG -0.235; TCGA LUAD -0.073; TCGA LUSC -0.126; TCGA PAAD -0.101; TCGA PRAD -0.081; TCGA UCEC -0.116 |
hsa-miR-3065-5p | TBC1D1 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.075; TCGA CESC -0.053; TCGA ESCA -0.186; TCGA LUAD -0.102; TCGA LUSC -0.057; TCGA PAAD -0.123; TCGA PRAD -0.128; TCGA THCA -0.054; TCGA UCEC -0.085 |
hsa-miR-3065-5p | PAPPA | 9 cancers: BLCA; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.141; TCGA ESCA -0.186; TCGA LGG -0.131; TCGA LUAD -0.125; TCGA LUSC -0.221; TCGA PAAD -0.18; TCGA PRAD -0.232; TCGA THCA -0.114; TCGA UCEC -0.266 |
hsa-miR-3065-5p | COL5A2 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; THCA; UCEC | MirTarget; mirMAP | TCGA BLCA -0.122; TCGA CESC -0.199; TCGA ESCA -0.164; TCGA LGG -0.245; TCGA LUAD -0.234; TCGA LUSC -0.345; TCGA PAAD -0.324; TCGA THCA -0.114; TCGA UCEC -0.116 |
hsa-miR-3065-5p | DCN | 10 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.299; TCGA CESC -0.139; TCGA ESCA -0.207; TCGA LGG -0.149; TCGA LUAD -0.07; TCGA LUSC -0.15; TCGA PAAD -0.271; TCGA PRAD -0.085; TCGA THCA -0.394; TCGA UCEC -0.354 |
hsa-miR-3065-5p | ACSL4 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; PAAD; PRAD; THCA; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.111; TCGA CESC -0.099; TCGA ESCA -0.083; TCGA LGG -0.054; TCGA LUAD -0.085; TCGA PAAD -0.106; TCGA PRAD -0.127; TCGA THCA -0.062; TCGA UCEC -0.145 |
hsa-miR-3065-5p | NUAK1 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.115; TCGA CESC -0.204; TCGA ESCA -0.121; TCGA LUAD -0.152; TCGA LUSC -0.22; TCGA PAAD -0.103; TCGA PRAD -0.077; TCGA THCA -0.075; TCGA UCEC -0.083 |
hsa-miR-3065-5p | ECM2 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.216; TCGA CESC -0.176; TCGA ESCA -0.187; TCGA LUAD -0.094; TCGA LUSC -0.209; TCGA PAAD -0.176; TCGA PRAD -0.084; TCGA THCA -0.152; TCGA UCEC -0.342 |
hsa-miR-3065-5p | RASGRF2 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.208; TCGA CESC -0.132; TCGA ESCA -0.195; TCGA LUAD -0.118; TCGA LUSC -0.207; TCGA PAAD -0.174; TCGA PRAD -0.094; TCGA THCA -0.1; TCGA UCEC -0.202 |
hsa-miR-3065-5p | CALD1 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.241; TCGA CESC -0.216; TCGA ESCA -0.241; TCGA LUAD -0.143; TCGA LUSC -0.161; TCGA PAAD -0.223; TCGA PRAD -0.166; TCGA THCA -0.105; TCGA UCEC -0.255 |
hsa-miR-3065-5p | BICC1 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.148; TCGA CESC -0.207; TCGA ESCA -0.212; TCGA LGG -0.272; TCGA LUAD -0.164; TCGA LUSC -0.304; TCGA PAAD -0.295; TCGA PRAD -0.299; TCGA THCA -0.152 |
hsa-miR-3065-5p | ALDH1L2 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.178; TCGA CESC -0.225; TCGA ESCA -0.147; TCGA LGG -0.16; TCGA LUAD -0.21; TCGA LUSC -0.141; TCGA PAAD -0.187; TCGA PRAD -0.206; TCGA THCA -0.377 |
hsa-miR-3065-5p | ADAMTS5 | 10 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.157; TCGA CESC -0.212; TCGA ESCA -0.252; TCGA LGG -0.097; TCGA LUAD -0.281; TCGA LUSC -0.219; TCGA PAAD -0.155; TCGA PRAD -0.173; TCGA THCA -0.144; TCGA UCEC -0.237 |
hsa-miR-3065-5p | FBXO32 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.153; TCGA CESC -0.159; TCGA ESCA -0.203; TCGA LUAD -0.151; TCGA LUSC -0.272; TCGA PAAD -0.209; TCGA PRAD -0.15; TCGA THCA -0.138; TCGA UCEC -0.191 |
hsa-miR-3065-5p | EIF5A2 | 9 cancers: BLCA; CESC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.097; TCGA CESC -0.22; TCGA LGG -0.101; TCGA LUAD -0.165; TCGA LUSC -0.139; TCGA PAAD -0.14; TCGA PRAD -0.125; TCGA THCA -0.088; TCGA UCEC -0.124 |
hsa-miR-3065-5p | FAM198B | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.183; TCGA CESC -0.106; TCGA ESCA -0.176; TCGA LUAD -0.176; TCGA LUSC -0.2; TCGA PAAD -0.164; TCGA PRAD -0.127; TCGA THCA -0.061; TCGA UCEC -0.264 |
hsa-miR-3065-5p | FBN1 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PAAD; PRAD; UCEC | mirMAP | TCGA BLCA -0.224; TCGA CESC -0.203; TCGA ESCA -0.279; TCGA LGG -0.095; TCGA LUAD -0.175; TCGA LUSC -0.3; TCGA PAAD -0.292; TCGA PRAD -0.113; TCGA UCEC -0.224 |
hsa-miR-3065-5p | BCL2 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.155; TCGA CESC -0.167; TCGA ESCA -0.128; TCGA LUAD -0.122; TCGA LUSC -0.151; TCGA PAAD -0.121; TCGA PRAD -0.136; TCGA THCA -0.121; TCGA UCEC -0.267 |
hsa-miR-3065-5p | SYNPO2 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.528; TCGA CESC -0.206; TCGA ESCA -0.391; TCGA LUAD -0.095; TCGA LUSC -0.144; TCGA PAAD -0.154; TCGA PRAD -0.293; TCGA THCA -0.123; TCGA UCEC -0.407 |
hsa-miR-3065-5p | ABCD2 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.324; TCGA CESC -0.16; TCGA ESCA -0.294; TCGA LGG -0.298; TCGA LUAD -0.09; TCGA LUSC -0.155; TCGA PRAD -0.249; TCGA THCA -0.307; TCGA UCEC -0.204 |
hsa-miR-3065-5p | GNG2 | 9 cancers: BLCA; CESC; ESCA; LGG; LUAD; LUSC; PRAD; THCA; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.193; TCGA CESC -0.172; TCGA ESCA -0.165; TCGA LGG -0.182; TCGA LUAD -0.057; TCGA LUSC -0.125; TCGA PRAD -0.085; TCGA THCA -0.143; TCGA UCEC -0.166 |
hsa-miR-3065-5p | PRELP | 9 cancers: BLCA; CESC; ESCA; LGG; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP | TCGA BLCA -0.404; TCGA CESC -0.203; TCGA ESCA -0.252; TCGA LGG -0.12; TCGA LUSC -0.229; TCGA PAAD -0.237; TCGA PRAD -0.137; TCGA THCA -0.213; TCGA UCEC -0.338 |
hsa-miR-3065-5p | TCF4 | 9 cancers: BLCA; CESC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | mirMAP; miRNATAP | TCGA BLCA -0.164; TCGA CESC -0.197; TCGA LGG -0.06; TCGA LUAD -0.096; TCGA LUSC -0.078; TCGA PAAD -0.171; TCGA PRAD -0.107; TCGA THCA -0.068; TCGA UCEC -0.18 |
hsa-miR-3065-5p | TSHZ3 | 9 cancers: BLCA; CESC; ESCA; LUAD; LUSC; PAAD; PRAD; THCA; UCEC | miRNATAP | TCGA BLCA -0.283; TCGA CESC -0.154; TCGA ESCA -0.147; TCGA LUAD -0.137; TCGA LUSC -0.166; TCGA PAAD -0.115; TCGA PRAD -0.089; TCGA THCA -0.076; TCGA UCEC -0.266 |
Enriched cancer pathways of putative targets